home All News open_in_new Full Article

Cytokinetics heart failure drug aficamten sees FDA decision delay

Cytokinetics heart failure drug aficamten sees FDA decision delay - San Francisco Business Times  The Business Journals


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Transport
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Technology
attach_file Politics
attach_file Science
attach_file Events
attach_file Events


ID: 288342217
Add Watch Country

arrow_drop_down